Publication Name	World Journal of Gastroenterology
Manuscript ID	9355
Country	China

Received	2014-02-09 15:32
Peer-Review Started	2014-02-10 13:43
First Decision by Editorial Office Director
Return for Revision	2014-03-13 18:08
Revised	2014-03-20 18:44
Publication Fee Transferred
Second Decision by Editor	2014-04-23 09:40
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-04-23 10:27
Articles in Press	2014-05-23 10:36
Edit the Manuscript by Language Editor	2014-07-22 15:12
Typeset the Manuscript	2014-08-13 16:54
Publish the Manuscript Online	2014-08-29 11:57

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Retrospective Study
Article Title	''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation
Manuscript Source	Unsolicited Manuscript
All Author List	Jun-Jun Jia, Bin-Yi Lin, Jiang-Juan He, Lei Geng, Dhruba Kadel, Li Wang, Dong-Dong Yu, Tian Shen, Zhe Yang, Yu-Fu Ye, Lin Zhou and Shu-Sen Zheng
Funding Agency and Grant Number	Funding Agency Grant Number National S and T Major Program 2012ZX10002004 National Natural Science Foundation of China 81373160 National Natural Science Foundation of China 81302074
Corresponding Author	Correspondence to: Shu-Sen Zheng, MD, PhD, FACS, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital of Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou 310003, Zhejiang Province, China. shusenzheng@zju.edu.cn
Key Words	Tacrolimus; Liver transplantation; Outcome; Minimizing tacrolimus; Immunosuppressive drug
Core Tip	Liver transplantation (LT) is a life-saving technique for patients with end-stage liver disease. Tacrolimus (TAC) is the cornerstone immunosuppressant for prevention of graft rejection in many LT centers. However, frequent TAC-related toxicities are observed and these are a major concern in LT patients. Thus, the ‘‘minimizing tacrolimus’’ strategy after LT is very important, especially in the early phase.
Publish Date	2014-08-29 11:57
Citation	Jia JJ, Lin BY, He JJ, Geng L, Kadel D, Wang L, Yu DD, Shen T, Yang Z, Ye YF, Zhou L, Zheng SS. “Minimizing tacrolimus’’ strategy and long-term survival after liver transplantation. World J Gastroenterol 2014; 20(32): 11363-11369
URL	http://www.wjgnet.com/1007-9327/full/v20/i32/11363.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i32.11363

Full Article (PDF)	WJG-20-11363.pdf
Full Article (Word)	WJG-20-11363.doc
Manuscript File	9355-Review.doc
Answering Reviewers	9355-Answering reviewers.pdf
Copyright License Agreement	9355-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	9355-Language certificate.PDF
Peer-review Report	9355-Peer reviews.pdf
Scientific Editor Work List	9355-Scientific editor work list.doc